REGULATED PRESS RELEASE published on 08/05/2024 at 17:45, 2 years 3 months ago Disclosure of trading in own shares from July 29th, 2024, to August 2nd, 2024. Detailed information per transaction
REGULATED PRESS RELEASE published on 08/05/2024 at 17:45, 2 years 3 months ago Déclaration des transactions sur actions propres réalisées du 29 juillet 2024 au 2 août 2024. Présentation détaillée transaction par transaction
REGULATED PRESS RELEASE published on 08/05/2024 at 17:45, 2 years 3 months ago Disclosure of trading in own shares from July 29th, 2024, to August 2nd, 2024 Lagardère SA discloses trading in own shares from July 29th to August 2nd, 2024. Total volume: 11,901 shares, average price per day: €22.4273 Trading Disclosure Lagardère SA Investor Relations Own Shares Stock Market
REGULATED PRESS RELEASE published on 08/05/2024 at 17:45, 2 years 3 months ago Déclaration des transactions sur actions propres réalisées Du 29 juillet 2024 au 02 août 2024 Déclaration des transactions sur actions propres de Lagardère SA du 29 juillet 2024 au 02 août 2024 conformément à la réglementation applicable Transactions Sur Actions Propres Lagardère SA Réglementation Achats D'actions Mandat
BRIEF published on 08/01/2024 at 17:50, 2 years 3 months ago Lagardère Announces Monthly Voting Rights and Share Capital Information Share Capital Voting Rights Financial Disclosure AMF Regulations LAGARDERE
BRIEF published on 08/01/2024 at 17:50, 2 years 3 months ago Nombre de droits de vote et d'actions de Lagardère au 31 juillet 2024 Droits De Vote Capital Social Actions AMF LAGARDERE
REGULATED PRESS RELEASE published on 08/01/2024 at 17:45, 2 years 3 months ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL Monthly information on voting rights and shares of Lagardère SA for July 31, 2024, as per French regulations Share Capital Voting Rights French Regulations Monthly Information Lagardère SA
REGULATED PRESS RELEASE published on 08/01/2024 at 17:45, 2 years 3 months ago INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET AU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL SOCIAL Publication mensuelle du nombre total de droits de vote et d'actions composant le capital social de Lagardère SA pour juillet 2024 Droits De Vote Capital Social Lagardère SA AMF Paris
BRIEF published on 07/29/2024 at 17:50, 2 years 3 months ago Lagardère Discloses Share Buybacks from July 22 to July 26, 2024 Trading Disclosure Share Buyback BNP Paribas LAGARDERE Employee Allocation
BRIEF published on 07/29/2024 at 17:50, 2 years 3 months ago Lagardère SA annonce ses transactions sur actions propres Actions Propres Transactions BNP Paribas Marchés Financiers LAGARDERE
Published on 11/06/2026 at 22:15, 2 days 9 hours ago Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 2 days 19 hours ago Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 2 days 19 hours ago Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 2 days 19 hours ago Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/09/2026 at 07:30, 39 minutes ago Hannover Re increases Group profit and confirms full-year guidance
Published on 11/09/2026 at 07:30, 39 minutes ago SUSS Expands Photomask Portfolio with Next-Generation ASC9500 Mid-End Cleaner
Published on 11/09/2026 at 07:30, 39 minutes ago GEA delivers strong third quarter: order intake rises substantially, revenue and profitability further improved
Published on 11/09/2026 at 07:30, 39 minutes ago Nordex Group to enter Albania with 84 MW order from Verbund
Published on 11/09/2026 at 07:30, 39 minutes ago q.beyond posts high volume of one-off charges in Q3 2026 – restructuring set to pay off from 2027 onwards
Published on 11/09/2026 at 07:00, 1 hour 9 minutes ago bioMérieux receives U.S. FDA 510(k) clearance for the latest versions of the BIOFIRE® FILMARRAY® Gastrointestinal Panels to enhance detection of gastrointestinal pathogens including norovirus
Published on 11/09/2026 at 07:00, 1 hour 9 minutes ago BIOPHYTIS ANNOUNCES THE OPERATIONAL LAUNCH OF ITS JOINT VENTURE IN CHINA
Published on 11/09/2026 at 07:00, 1 hour 9 minutes ago Biophytis annonce le démarrage opérationnel de sa co-entreprise en Chine
Published on 11/09/2026 at 07:00, 1 hour 9 minutes ago bioMérieux obtient l’autorisation 510(k) de la FDA américaine pour les dernières versions des tests BIOFIRE® FILMARRAY® Gastrointestinal Panels afin d’optimiser la détection des pathogènes gastrointestinaux, dont le norovirus
Published on 11/06/2026 at 19:06, 2 days 13 hours ago ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
